Bernhardt Zeiher
Director/Board Member at ENTRADA THERAPEUTICS, INC.
Net worth: - $ as of 31/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Justin Klee | M | 33 | 11 years | |
| Josh Cohen | M | 32 | 11 years | |
| Dipal Doshi | M | 48 | 7 years | |
| Kush Parmar | M | 42 | 8 years | |
| George Milne | M | 80 | 9 years | |
| Karla MacDonald | F | - | 3 years | |
| Hiroshi Kawabe | M | 72 | 5 years | |
| Mary Thistle | F | 64 | 3 years | |
| Tatsuro Ishizuka | M | 68 | 5 years | |
| Nathan Dowden | M | 54 | 5 years | |
| Daphne Quimi | F | 58 | 3 years | |
| Kory Wentworth | M | 45 | 4 years | |
| Kari Firestone | F | 68 | 1 years | |
| Paul R. Fonteyne | M | 62 | 3 years | |
| Janice Chang | F | - |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | 10 years |
| Hiroo Sasaki | M | 68 | 6 years | |
| Natarajan Sethuraman | M | 62 | 7 years | |
| Keisuke Mitsuoka | M | - | 3 years | |
| Kerry Robert | F | - | - | |
| Jared Cohen | M | - | 4 years | |
| Steffen Roellinger | M | - |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
| Gina Mazzariello | F | 52 | 2 years | |
| Rudy Tanzi | M | - | 10 years | |
| Lindsey Allen | F | - | - | |
| Peter Kim | M | 65 | 4 years | |
| Takuko Yamada-Sawada | F | - |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | 10 years |
| Claudia Mitchell | M | - | 5 years | |
| Haruko Shibumura | F | 59 | 5 years | |
| William Pao | M | 57 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
| Alexander Roderick MacKenzie | M | 65 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
| Takashi Tanaka | M | 67 | 3 years | |
| Gina Chapman | F | 57 | 1 years | |
| C. Nicholson | M | 69 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | 7 years |
| Brian Daniels | M | 65 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
| Jan Lundberg | M | 71 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
| Steven Gilman | M | 71 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
| Camille Bedrosian | M | 71 | 1 years | |
| Jim Frates | M | 56 | 3 years | |
| Kathryn Owen | F | - |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sef P. Kurstjens | M | 60 |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | 8 years |
| John Crowley | M | 57 | 4 years | |
| Carole Nüchterlein | F | 62 | 3 years | |
| Wendy Yarno | F | 68 | 9 years | |
| Larry G. Edwards | M | 52 | 15 years | |
| Anne Tatlock | F | 84 | - | |
| William Harrison | M | 80 | - | |
| Jin Kanamori | M | 69 | - | |
| Todd Foley | M | 52 | 5 years | |
| Laura Sepp-Lorenzino | M | 63 | 15 years | |
| Glenn Williams | M | - | 10 years | |
| Jeannette A. Barrett | M | - |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | 1 years |
| Percival Barretto-Ko | M | 51 | - | |
| Eric W. Kimble | M | 58 | 5 years | |
| Eduardo O. Thompson | M | - | 6 years | |
| Nerissa Kreher | M | 51 | 4 years | |
| Sarah S. Toomey | F | 50 | 3 years | |
| Mark Timney | M | 58 | 15 years | |
| François Meurgey | M | - | - | |
| Benito Munoz | M | 62 | 9 years | |
| Stephen Eck | M | 69 |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | 6 years |
| Silvana Battaglia | F | 56 | 10 years | |
| Stig Ogata | M | - | - | |
| Michael Rafa | M | - | - | |
| Amit Hasija | M | 51 | 5 years | |
| Jeffrey Ludwig | M | 58 | 1 years | |
| Kimberly Murphy | F | 62 | 6 years | |
| Satoshi Konagai | M | - | 5 years | |
| Nobuaki Shindoh | M | - | 8 years | |
| Soren Christiansen | M | 68 | 19 years | |
| Hiromichi Kimura | M | 73 | 4 years | |
| Charles Popper | M | - | 7 years | |
| James Villalobos | M | 55 | - | |
| Robert G. Johnson | M | 72 | 7 years | |
| Beth Seidenberg | M | 67 | 2 years | |
| Paul Howes | M | 69 | 5 years | |
| Simon Benito | M | 79 | 25 years | |
| David Arkowitz | M | 62 | 3 years | |
| Albert I. Wertheimer | M | 81 | 3 years | |
| Ronald Newbold | M | 61 | 9 years | |
| Edward Hu | M | 61 | 2 years | |
| Timothy Walbert | M | 57 | 1 years | |
| Hugh Johnston | M | 62 | 3 years | |
| Heidi Miller | M | 70 | 4 years | |
| Erskine B. Bowles | M | 78 | 2 years | |
| Margaret McGlynn | F | 64 | 11 years | |
| Dorothy P. Bowers | F | - | - | |
| Vijay Samant | M | 77 | 23 years | |
| William G. Roberts | M | 66 | 6 years | |
| Gregory S. Patrick | M | 72 | 14 years | |
| John Bostjancic | M | 53 | 1 years | |
| Gerald J. Gallivan | M | - | - | |
| Penny M. Heaton | M | 59 | 7 years | |
| Jim Hinrichs | M | 56 | 5 years | |
| Kamil Ali-Jackson | F | 65 | 8 years | |
| Thomas A. Reed | M | - | 1 years | |
| Elizabeth Hamilton Seabury Wyatt | M | 76 | 20 years | |
| Christine Bunt | F | - | 7 years | |
| David Barrett | M | - | 17 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 82 | 83.67% |
| Japan | 17 | 17.35% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bernhardt Zeiher
- Personal Network
